Improving Clinical Decision Making with Engaging CME, Tools, & Resources
Gene Therapy for nAMD: Navigating the Next Era of Durable Retinal Treatment
Szilard Kiss, MD
Carl D. Regillo, MD, FACS, FASRS
Lejla Vajzovic, MD, FASRS
Gene Therapy for nAMD: Focus on Future Readiness
Retinas at Risk: Real-World Cases in High Disease Activity and Adherence Challenges
How Gene Therapy Is Designed to Work in Retinal Disease
Interpreting Gene Therapy Data With Confidence
Seeing the Cornea Clearly
Jacob Lang
Seeing the Signs of Dry Eye Disease
Steve Jackson, PharmD
John D. Sheppard, MD
EMPOWER - Ocular Surface Disease: Latest Innovations In Dry Eye And Meibomian Gland Dysfunction
Josh Davidson, OD, FSLS, FAAO
Mark Dunbar
Uncovering the Drivers of Dry Eye Symptoms
Anat Galor, MD, MSPH
Rethinking Dry Eye Disease: Evolving Strategies for Evaluation and Care
Esen K. Akpek, MD
Geographic Atrophy: A Personalized Approach
Charles Turck, PharmD, BCPS, BCCCP
Jonathan Jonisch, MD
Novel Approaches in Early and Intermediate AMD: A Mechanistic Deep Dive
Diana V. Do, MD
Janis T. Eells, Ph.D.
David Boyer, MD
Eleonora Lad, MD, PhD
Marion R. Munk, MD, PhD
Redefining Durability in nAMD: The Science and Strategy of Sustained-Delivery TKIs
Ashkan Abbey, MD
Rishi Singh, MD, FASRS
Improving Early Detection of Geographic Atrophy
Alexandria May, PharmD, BCPS
Hasenin Al-khersan, MD
Extended Dosing Strategies for Diabetic Retinopathy and DME
Michael A. Klufas, MD
Diagnostic Vitrectomy for Infectious Uveitis
Steven Yeh, MD, FASRS
Loading...
We're glad to see you're enjoying Eye Health Academy… but how about a more personalized experience?
Press cancel to remain on Eye Health Academy. Press the link below or the continue button to keep going.